Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2017-09, Vol.28, p.v480-v481 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | v481 |
|---|---|
| container_issue | |
| container_start_page | v480 |
| container_title | Annals of oncology |
| container_volume | 28 |
| creator | Ou, S.-H.I. Tiseo, M. Camidge, R. Ahn, M.-J. Huber, R.M. Hochmair, M.J. Kim, S.-W. West, H.L. Reckamp, K.L. Molina, J.R. Liu, G. Delmonte, A. Viteri, S. Bearz, A. Summers, Y. Reichmann, W. Kerstein, D. Gettinger, S.N. Kim, D.-W. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx380.047 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdx380_047</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdx380_047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1337-54922009878ee5adc4a0792e0f84e77ce0bcfba3957d5447460d89216115def33</originalsourceid><addsrcrecordid>eNotkE1PhDAQhjlo4ucP8DZHOKCFwpYeV-JXJGp2NSZeyFCKW4VC2mrE_-f_sma9zCRvZp7MPEFwkpDThHB6hlqPWpwN7RctyCnJ2E6wT3hKY5bTbC84sPaNELLgKd8Pfm60MygMaoU9yK5TAsUMYweNUa_olFYNhOerqwiUhskHUjsL4YOzETwrtwFh1Pf4P1euXqLYyM4T3WhmQI1Tj9YpAf08TJtxQHhXGq2EcFndRvE0WuXUpwR_cWwH7HsQ0pf-Q7-CQC2kgfBuXVZl5GEtNH61V1pCebeGQTrP9ok9CnY77K08_u-HwdPlxWN5HVf3VzflsopFQimL84ynKSG8YIWUObYiQ8J4KklXZJIxIUkjugYpz1mbZxnLFqQteJoskiRvZUfpYZBsucKM1vpH68moAc1cJ6T-c19v3ddb97V3T38B6HB-CA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ou, S.-H.I. ; Tiseo, M. ; Camidge, R. ; Ahn, M.-J. ; Huber, R.M. ; Hochmair, M.J. ; Kim, S.-W. ; West, H.L. ; Reckamp, K.L. ; Molina, J.R. ; Liu, G. ; Delmonte, A. ; Viteri, S. ; Bearz, A. ; Summers, Y. ; Reichmann, W. ; Kerstein, D. ; Gettinger, S.N. ; Kim, D.-W.</creator><creatorcontrib>Ou, S.-H.I. ; Tiseo, M. ; Camidge, R. ; Ahn, M.-J. ; Huber, R.M. ; Hochmair, M.J. ; Kim, S.-W. ; West, H.L. ; Reckamp, K.L. ; Molina, J.R. ; Liu, G. ; Delmonte, A. ; Viteri, S. ; Bearz, A. ; Summers, Y. ; Reichmann, W. ; Kerstein, D. ; Gettinger, S.N. ; Kim, D.-W.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdx380.047</identifier><language>eng</language><ispartof>Annals of oncology, 2017-09, Vol.28, p.v480-v481</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1337-54922009878ee5adc4a0792e0f84e77ce0bcfba3957d5447460d89216115def33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Ou, S.-H.I.</creatorcontrib><creatorcontrib>Tiseo, M.</creatorcontrib><creatorcontrib>Camidge, R.</creatorcontrib><creatorcontrib>Ahn, M.-J.</creatorcontrib><creatorcontrib>Huber, R.M.</creatorcontrib><creatorcontrib>Hochmair, M.J.</creatorcontrib><creatorcontrib>Kim, S.-W.</creatorcontrib><creatorcontrib>West, H.L.</creatorcontrib><creatorcontrib>Reckamp, K.L.</creatorcontrib><creatorcontrib>Molina, J.R.</creatorcontrib><creatorcontrib>Liu, G.</creatorcontrib><creatorcontrib>Delmonte, A.</creatorcontrib><creatorcontrib>Viteri, S.</creatorcontrib><creatorcontrib>Bearz, A.</creatorcontrib><creatorcontrib>Summers, Y.</creatorcontrib><creatorcontrib>Reichmann, W.</creatorcontrib><creatorcontrib>Kerstein, D.</creatorcontrib><creatorcontrib>Gettinger, S.N.</creatorcontrib><creatorcontrib>Kim, D.-W.</creatorcontrib><title>Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNotkE1PhDAQhjlo4ucP8DZHOKCFwpYeV-JXJGp2NSZeyFCKW4VC2mrE_-f_sma9zCRvZp7MPEFwkpDThHB6hlqPWpwN7RctyCnJ2E6wT3hKY5bTbC84sPaNELLgKd8Pfm60MygMaoU9yK5TAsUMYweNUa_olFYNhOerqwiUhskHUjsL4YOzETwrtwFh1Pf4P1euXqLYyM4T3WhmQI1Tj9YpAf08TJtxQHhXGq2EcFndRvE0WuXUpwR_cWwH7HsQ0pf-Q7-CQC2kgfBuXVZl5GEtNH61V1pCebeGQTrP9ok9CnY77K08_u-HwdPlxWN5HVf3VzflsopFQimL84ynKSG8YIWUObYiQ8J4KklXZJIxIUkjugYpz1mbZxnLFqQteJoskiRvZUfpYZBsucKM1vpH68moAc1cJ6T-c19v3ddb97V3T38B6HB-CA</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>Ou, S.-H.I.</creator><creator>Tiseo, M.</creator><creator>Camidge, R.</creator><creator>Ahn, M.-J.</creator><creator>Huber, R.M.</creator><creator>Hochmair, M.J.</creator><creator>Kim, S.-W.</creator><creator>West, H.L.</creator><creator>Reckamp, K.L.</creator><creator>Molina, J.R.</creator><creator>Liu, G.</creator><creator>Delmonte, A.</creator><creator>Viteri, S.</creator><creator>Bearz, A.</creator><creator>Summers, Y.</creator><creator>Reichmann, W.</creator><creator>Kerstein, D.</creator><creator>Gettinger, S.N.</creator><creator>Kim, D.-W.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201709</creationdate><title>Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases</title><author>Ou, S.-H.I. ; Tiseo, M. ; Camidge, R. ; Ahn, M.-J. ; Huber, R.M. ; Hochmair, M.J. ; Kim, S.-W. ; West, H.L. ; Reckamp, K.L. ; Molina, J.R. ; Liu, G. ; Delmonte, A. ; Viteri, S. ; Bearz, A. ; Summers, Y. ; Reichmann, W. ; Kerstein, D. ; Gettinger, S.N. ; Kim, D.-W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1337-54922009878ee5adc4a0792e0f84e77ce0bcfba3957d5447460d89216115def33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ou, S.-H.I.</creatorcontrib><creatorcontrib>Tiseo, M.</creatorcontrib><creatorcontrib>Camidge, R.</creatorcontrib><creatorcontrib>Ahn, M.-J.</creatorcontrib><creatorcontrib>Huber, R.M.</creatorcontrib><creatorcontrib>Hochmair, M.J.</creatorcontrib><creatorcontrib>Kim, S.-W.</creatorcontrib><creatorcontrib>West, H.L.</creatorcontrib><creatorcontrib>Reckamp, K.L.</creatorcontrib><creatorcontrib>Molina, J.R.</creatorcontrib><creatorcontrib>Liu, G.</creatorcontrib><creatorcontrib>Delmonte, A.</creatorcontrib><creatorcontrib>Viteri, S.</creatorcontrib><creatorcontrib>Bearz, A.</creatorcontrib><creatorcontrib>Summers, Y.</creatorcontrib><creatorcontrib>Reichmann, W.</creatorcontrib><creatorcontrib>Kerstein, D.</creatorcontrib><creatorcontrib>Gettinger, S.N.</creatorcontrib><creatorcontrib>Kim, D.-W.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ou, S.-H.I.</au><au>Tiseo, M.</au><au>Camidge, R.</au><au>Ahn, M.-J.</au><au>Huber, R.M.</au><au>Hochmair, M.J.</au><au>Kim, S.-W.</au><au>West, H.L.</au><au>Reckamp, K.L.</au><au>Molina, J.R.</au><au>Liu, G.</au><au>Delmonte, A.</au><au>Viteri, S.</au><au>Bearz, A.</au><au>Summers, Y.</au><au>Reichmann, W.</au><au>Kerstein, D.</au><au>Gettinger, S.N.</au><au>Kim, D.-W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases</atitle><jtitle>Annals of oncology</jtitle><date>2017-09</date><risdate>2017</risdate><volume>28</volume><spage>v480</spage><epage>v481</epage><pages>v480-v481</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdx380.047</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2017-09, Vol.28, p.v480-v481 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdx380_047 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Intracranial efficacy of brigatinib (BRG) in patients (Pts) With crizotinib (CRZ)-refractory anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) and baseline CNS metastases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A24%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intracranial%20efficacy%20of%20brigatinib%20(BRG)%20in%20patients%20(Pts)%20With%20crizotinib%20(CRZ)-refractory%20anaplastic%20lymphoma%20kinase%20(ALK)-positive%20non-small%20cell%20lung%20cancer%20(NSCLC)%20and%20baseline%20CNS%20metastases&rft.jtitle=Annals%20of%20oncology&rft.au=Ou,%20S.-H.I.&rft.date=2017-09&rft.volume=28&rft.spage=v480&rft.epage=v481&rft.pages=v480-v481&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdx380.047&rft_dat=%3Ccrossref%3E10_1093_annonc_mdx380_047%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |